skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: data de publicação: Após 2012 remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials

Unger, Joseph M ; Vaidya, Riha ; Albain, Kathy S ; LeBlanc, Michael ; Minasian, Lori M ; Gotay, Carolyn C ; Henry, N Lynn ; Fisch, Michael J ; Lee, Shing M ; Blanke, Charles D ; Hershman, Dawn L

Journal of clinical oncology, 2022-05, Vol.40 (13), p.1474-1486 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
2
SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Ben-Josef, Edgar ; Guthrie, Katherine A ; El-Khoueiry, Anthony B ; Corless, Christopher L ; Zalupski, Mark M ; Lowy, Andrew M ; Thomas, Jr, Charles R ; Alberts, Steven R ; Dawson, Laura A ; Micetich, Kenneth C ; Thomas, Melanie B ; Siegel, Abby B ; Blanke, Charles D

Journal of clinical oncology, 2015-08, Vol.33 (24), p.2617-2622 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
3
In response: Diabetes is a risk factor for the progression and prognosis of COVID‐19
In response: Diabetes is a risk factor for the progression and prognosis of COVID‐19
Material Type:
Artigo 		Adicionar ao Meu Espaço

In response: Diabetes is a risk factor for the progression and prognosis of COVID‐19

Blanke, Charles D.

Diabetes/metabolism research and reviews, 2020-10, Vol.36 (7), p.e3331-n/a [Periódico revisado por pares]

Chichester, UK: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
4
Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database
Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database

Jin, Zhaohui ; Dixon, Jesse G ; Fiskum, Jack M ; Parekh, Hiral D ; Sinicrope, Frank A ; Yothers, Greg ; Allegra, Carmen J ; Wolmark, Norman ; Haller, Daniel ; Schmoll, Hans-Joachim ; de Gramont, Aimery ; Kerr, Rachel ; Taieb, Julien ; Van Cutsem, Eric ; Tweleves, Christopher ; O'Connell, Michael ; Saltz, Leonard B ; Sadahiro, Sotaro ; Blanke, Charles D ; Tomita, Naohiro ; Seitz, Jean-Francois ; Erlichman, Charles ; Yoshino, Takayuki ; Yamanaka, Takeharu ; Marsoni, Silvia ; Andre, Thierry ; Mahipal, Amit ; Goldberg, Richard M ; George, Thomas J ; Shi, Qian

JNCI : Journal of the National Cancer Institute, 2021-11, Vol.113 (12), p.1693-1704 [Periódico revisado por pares]

United States: Oxford University Press

Texto completo disponível

Citações Citado por
5
Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405
Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405
Material Type:
Artigo 		Adicionar ao Meu Espaço

Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405

Lipsyc-Sharf, Marla ; Zhang, Sui ; Ou, Fang-Shu ; Ma, Chao ; McCleary, Nadine Jackson ; Niedzwiecki, Donna ; Chang, I-Wen ; Lenz, Heinz-Josef ; Blanke, Charles D ; Piawah, Sorbarikor ; Van Loon, Katherine ; Bainter, Tiffany M ; Venook, Alan P ; Mayer, Robert J ; Fuchs, Charles S ; Innocenti, Federico ; Nixon, Andrew B ; Goldberg, Richard ; O’Reilly, Eileen M ; Meyerhardt, Jeffrey A ; Ng, Kimmie

JNCI : Journal of the National Cancer Institute, 2022-03, Vol.114 (3), p.427-435 [Periódico revisado por pares]

United States: Oxford University Press

Texto completo disponível

Citações Citado por
6
Symposium Introduction: A Decade of the Tobacco Control Act: Progress, Setbacks, and the Future of Tobacco Control
Symposium Introduction: A Decade of the Tobacco Control Act: Progress, Setbacks, and the Future of Tobacco Control
Material Type:
Artigo 		Adicionar ao Meu Espaço

Symposium Introduction: A Decade of the Tobacco Control Act: Progress, Setbacks, and the Future of Tobacco Control

Blanke, D. Douglas

The Journal of legal medicine (Chicago. 1979), 2020-07, Vol.40 (3-4), p.285-291 [Periódico revisado por pares]

United States: Taylor & Francis

Texto completo disponível

Citações Citado por
7
S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma
S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma

EL-KHOUEIRY, A. B ; RANKIN, C ; SIEGEL, A. B ; IQBAL, S ; GONG, I.-Y ; MICETICH, K. C ; KAYALEH, O. R ; LENZ, H.-J ; BLANKE, C. D

British journal of cancer, 2014-02, Vol.110 (4), p.882-887 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Population, Clinical, and Scientific Impact of National Cancer Institute's National Clinical Trials Network Treatment Studies
Population, Clinical, and Scientific Impact of National Cancer Institute's National Clinical Trials Network Treatment Studies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Population, Clinical, and Scientific Impact of National Cancer Institute's National Clinical Trials Network Treatment Studies

Unger, Joseph M ; LeBlanc, Michael ; George, Suzanne ; Wolmark, Norman ; Curran, Jr, Walter J ; O'Dwyer, Peter J ; Schnall, Mitchell D ; Mannel, Robert S ; Mandrekar, Sumithra J ; Gray, Robert J ; Zhao, Fengmin ; Bah, Mariama ; Vaidya, Riha ; Blanke, Charles D

Journal of clinical oncology, 2023-04, Vol.41 (11), p.2020-2028 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
9
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial

Gordon, M.A. ; Gundacker, H.M. ; Benedetti, J. ; Macdonald, J.S. ; Baranda, J.C. ; Levin, W.J. ; Blanke, C.D. ; Elatre, W. ; Weng, P. ; Zhou, J.Y. ; Lenz, H.J. ; Press, M.F.

Annals of oncology, 2013-07, Vol.24 (7), p.1754-1761 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors

Patel, Sandip P ; Othus, Megan ; Chae, Young Kwang ; Giles, Francis J ; Hansel, Donna E ; Singh, Preet Paul ; Fontaine, Annette ; Shah, Manisha H ; Kasi, Anup ; Baghdadi, Tareq Al ; Matrana, Marc ; Gatalica, Zoran ; Korn, W Michael ; Hayward, Jourdain ; McLeod, Christine ; Chen, Helen X ; Sharon, Elad ; Mayerson, Edward ; Ryan, Christopher W ; Plets, Melissa ; Blanke, Charles D ; Kurzrock, Razelle

Clinical cancer research, 2020-05, Vol.26 (10), p.2290-2296 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (309)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (319)
  2. Book Chapters  (101)
  3. Anais de Congresso  (8)
  4. Conjunto de Dados  (6)
  5. Livros  (3)
  6. Resenhas  (2)
  7. Audio  (1)
  8. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2014  (22)
  2. 2014Até2015  (82)
  3. 2016Até2017  (163)
  4. 2018Até2020  (83)
  5. Após 2020  (91)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (433)
  2. Japonês  (33)
  3. Francês  (5)
  4. Espanhol  (3)
  5. Português  (1)
  6. Alemão  (1)
  7. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.